BridgeBio Pharma Inc (BBIO)
US$ 33.870.06%
Price Chart
Key Statistics
Market Cap
$ 6.4B
P/E Ratio
0.00
Revenue (TTM)
$ 127.42M
Volume
1.47M
52W High
$ 39.54
52W Low
$ 21.62
Dividend Yield
0.00%
Beta
1.15
Technicals
50-Day MA
34.4375
200-Day MA
29.7545
52 Week High
39.54
52 Week Low
21.62
About BBIO
BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.
Employees
725
Headquarters
Palo Alto, CA
CEO
Dr. Neil Kumar Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg